Immunogen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

19.22USD
10:49am EDT
Price Change (% chg)

$0.17 (+0.89%)
Prev Close
$19.05
Open
$19.25
Day's High
$19.35
Day's Low
$19.11
Volume
63,272
Avg. Vol
209,573
52-wk High
$19.98
52-wk Low
$10.85

IMGN.OQ

Chart for IMGN.OQ

About

ImmunoGen, Inc. (ImmunoGen) develops targeted, antibody-based therapeutics for the treatment of cancer. ImmunoGen designs linkers that enable antibody-based therapeutics for the treatment of cancer agents to remain stably attached to the antibodies while in the blood stream and be released in their fully active form after... (more)

Overall

Beta: 1.64
Market Cap (Mil.): $1,610.37
Shares Outstanding (Mil.): 84.53
Dividend: --
Yield (%): --

Financials

  IMGN.OQ Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -0.90 -- --
ROI: -37.29 -2.58 18.76
ROE: -61.14 -2.66 19.59
Search Stocks

CORRECTED-UPDATE 3-FDA approves Roche drug for late-stage breast cancer

(Corrects paragraph 5 to show control arm included Xeloda, not Herceptin)

22 Feb 2013

UPDATE 3-FDA approves Roche drug for late-stage breast cancer

* ImmunoGen shares up 1.9 pct; Roche up 1.5 pct (Adds additional analyst comment, background)

22 Feb 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$460.00
Provider: S&P Capital IQ Quantitative Report
$58.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks